『2 Minutes with Joey - CRSP Stock News』のカバーアート

2 Minutes with Joey - CRSP Stock News

2 Minutes with Joey - CRSP Stock News

著者： 2 Minutes with Joey
無料で聴く

Two minutes with Joey on CRISPR Therapeutics (CRSP) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.Copyright 2 Minutes with Joey 社会科学
エピソード
  • CRSP Today - Aug 13: Bank of America Sells Shares

    CRSP Today - Aug 13: Bank of America Sells Shares
    2026/08/13
    Hey there! It’s Joey here, your friendly long-time investor, breaking down what went down with CRISPR Therapeutics today. So, CRSP had a red day, slipping just a tad, down 0.15%. Not a huge drop, but still, nobody likes to see red.

    So, what happened? It looks like Bank of America decided to trim its position in CRISPR. They sold off some shares, and you know how that goes; when a big player makes a move like that, people start hitting the sell button fast. Even though we're talking a minor drop, it can really shake things up, especially when folks are already a bit jittery about the biotech sector.

    Now, let’s chat about the why behind this move. The news from Bank of America was pretty big today, and it’s always a bummer when a major player like that starts pulling back. It creates a ripple effect, and investors start to wonder if there's something deeper going on. There’s also been some talk about CRISPR’s recent financials showing stronger revenue and a narrower loss, which could change the game for folks considering investing. But, with news like the Bank of America sell-off, it’s hard to see the silver lining for now.

    Oh, and here's something worth keeping an eye on: CRISPR’s CFO just gifted 750 shares. That’s kinda interesting, right? It could mean they’re feeling confident about the future, or maybe it's just a nice gesture. Either way, it’s a little tidbit that could spark some curiosity among investors.

    To wrap it up, CRISPR had a bit of a rough day with that Bank of America news. But hey, the biotech world is always a wild ride, and it’s not all doom and gloom. Keep your chin up! Remember, I’m just here sharing the info and having a little fun with the stock talk. No financial advice, just good vibes. Catch you later!
    続きを読む 一部表示
    2 分
  • CRSP Today - Aug 12: Mixed Signals for CRISPR

    CRSP Today - Aug 12: Mixed Signals for CRISPR
    2026/08/12
    Hey there! It’s Joey, your friendly longtime investor, here to break down what went down with CRISPR Therapeutics today. So, CRSP had a bit of a red day, slipping down by half a percent. Yeah, that one stung a little.

    Now, let’s get into the nitty-gritty. The stock barely moved, but there’s some chatter around the company that’s worth mentioning. They reported stronger revenue and a narrower loss, which is usually a good sign. People love to see that kind of progress! But it seems like the market's still trying to figure out what to make of it all. Sometimes, good news doesn’t translate into stock gains right away, and today was one of those days.

    In the background, CRISPR’s CFO, Prasad Raju, made a little splash by gifting 750 shares. That’s kind of a cool move, right? It shows some confidence in the company. Meanwhile, it looks like Quantinno Capital Management is raising its position in CRISPR. That’s definitely something to keep an eye on, as it suggests some folks are still betting on the future here.

    Now, here's a quick fact for you: the FDA recently approved some products for three biotech companies, which is huge news for the industry. This could be a game-changer for CRISPR and its peers, so it’s worth watching how that plays out.

    So, to wrap it up, CRSP had a quiet day, but there’s some interesting stuff happening behind the scenes. Always good to keep your ears to the ground! Remember, this is just for fun and to keep you informed, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • CRSP Today - Aug 11: Small Dip Amid Updates

    CRSP Today - Aug 11: Small Dip Amid Updates
    2026/08/11
    Hey there! It's Joey, your friendly investor buddy, here to break down what went down with CRISPR Therapeutics today. So, CRSP had a bit of a rough day, dipping just a smidge, down about 0.11%. Not a huge drop, but still, a dip is a dip, right?

    Now, what happened? Well, the stock kinda floated around without making any real waves. It opened, traded, and closed pretty much in the same range. Volume was steady, but nothing crazy. Just one of those days where it felt like the market was taking a breather.

    So, why the movement? Honestly, nobody really knows for sure. There were some updates about CRISPR's stock position being raised by Quantinno Capital Management, which usually sounds like good news. But it didn’t really fire up the stock. Plus, there were some mixed vibes in the market about other gene-editing companies like Intellia Therapeutics, which might’ve added to the uncertainty. Sometimes, when one stock's not doing well, it drags others down too.

    And here’s a quick note: there’s been chatter about CRISPR's commercial collaborations and pipeline focus. So, keep an eye on that. Could be something cooking in the background that might shake things up later.

    Alright, that’s the scoop! Just remember, this is all for fun and info—no financial advice here. Catch you later!
    続きを読む 一部表示
    1 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません